Usefulness of Preoperative C-Reactive Protein and Soluble Intercellular Adhesion Molecule-1 Level for Predicting Future Cardiovascular Events After Coronary Artery Bypass Grafting

American Journal of Cardiology

Volumn 97, Issue 12, 2006, Pages 1697-1701

  van der Harst, Pim ^a   Voors, Adriaan A ^a   Volbeda, Meint ^a   Buikema, Hendrik ^a   van Veldhuisen, Dirk J ^a   van Gilst, Wiek H ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HEART DEATH; HEART INFARCTION; HUMAN; INCIDENCE; LOW TEMPERATURE PROCEDURES; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; REOPERATION; STORAGE; STROKE;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CEREBROVASCULAR ACCIDENT; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; REGRESSION ANALYSIS; REOPERATION; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 33744525855     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.01.030     Document Type: Article

References (16)

1. Ridker P.M., Hennekens C.H., Roitman-Johnson B., Stampfer M.J., and Allen J. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351 (1998) 88-92
2. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
3. Ridker P.M., Rifai N., Pfeffer M.A., Sacks F.M., Moye L.A., Goldman S., Flaker G.C., Braunwald E., and Cholesterol and Recurrent Events (CARE) Investigators. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98 (1998) 839-844
4. Buffon A., Liuzzo G., Biasucci L.M., Pasqualetti P., Ramazzotti V., Rebuzzi A.G., Crea F., and Maseri A. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol 34 (1999) 1512-1521
5. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schachinger V., and Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J Am Coll Cardiol 37 (2001) 839-846
6. Biancari F., Lahtinen J., Lepojarvi S., Rainio P., Salmela E., Pokela R., Lepojarvi M., Satta J., and Juvonen T.S. Preoperative C-reactive protein and outcome after coronary artery bypass surgery. Ann Thorac Surg 76 (2003) 2007-2012
7. Pradhan A.D., Rifai N., and Ridker P.M. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 106 (2002) 820-825
8. Oosterga M., Voors A.A., Buikema H., Pinto Y.M., Haber H.E., Ebels T., Morshuis W.J., Kingma J.H., Crijns H.J., van Gilst W.H., and QUO VADIS Investigators. Angiotensin II formation in human vasculature after chronic ACE inhibition. a prospective, randomized, placebo-controlled study. Cardiovasc Drugs Ther 14 (2000) 55-60
9. van Haelst P.L., Tervaert J.W., van Geel P.P., Veeger N.J., Gurne O., Gans R.O., and van Gilst W.H. Long term angiotensin converting enzyme-inhibition in patients after coronary artery bypass grafting reduces levels of soluble intercellular cell adhesion molecule-1. Eur J Vasc Endovasc Surg 26 (2003) 387-391
10. van der Harst P., Volbeda M., Voors A.A., Buikema H., Wassmann S., Bohm M., Nickenig G., and van Gilst W.H. Vascular response to angiotensin II predicts long-term prognosis in patients undergoing coronary artery bypass grafting. Hypertension 44 (2004) 930-934
11. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L., and FRISC Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
12. Di Napoli M., and Papa F. Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke 33 (2002) 1763-1771
13. Zebrack J.S., Muhlestein J.B., Horne B.D., and Anderson J.L. C-reactive protein and angiographic coronary artery disease. independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39 (2002) 632-637
14. Gaudino M., Nasso G., Andreotti F., Minniti G., Iacoviello L., Donati M., Schiavello R., and Possati G. Preoperative C-reactive protein level and outcome following coronary surgery. Eur J Cardiothorac Surg 22 (2002) 521-526
15. Milazzo D., Biasucci L.M., Luciani N., Martinelli L., Canosa C., Schiavello R., Maseri A., and Possati G. Elevated levels of C-reactive protein before coronary artery bypass grafting predict recurrence of ischemic events. Am J Cardiol 84 (1999) 459-461
16. Ridker P.M., Cannon C.P., Morrow D., Rifai N., Rose L.M., McCabe C.H., Pfeffer M.A., and Braunwald E. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28